Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
Paul Decker, T. Moulinet, Benjamín López, Sylvain Dubucquoi, Bernard Bonnotte, Daniela Lakomy, Sabine Revuz, Amandine Luc, Manoel de Carvalho, É. Hachulla, R. Jaussaud
Topics & Concepts
CTDMedicineAntibodyConnective tissue diseaseAntisynthetase syndromeInternal medicineSystemic sclerodermaSystemic diseasePathologyAutoantibodyImmunologyDiseaseAutoimmune diseaseOceanographyGeologyInflammatory Myopathies and DermatomyositisSystemic Sclerosis and Related DiseasesLiver Diseases and Immunity